New Research in Treating Infantile-Onset Pompe Disease
Thanks to a new prenatal therapy protocol by Dr. Tippi MacKenzie and the UCSF Center for Maternal-Fetal Precision Medicine, a toddler Ayla has hit developmental milestones despite having a genetic disease that took her siblings' lives.
A new case study released in the New England Journal of Medicine discusses successful in utero enzyme replacement treatment of a fetus with infantile-onset Pompe—a lysosomal storage disease. Infantile-onset Pompe’s disease is caused by a genetic deficiency of an enzyme critical to heart development.
More information can be found on: